Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]
“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.” The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]
“In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information Make no mistake, the in vitro diagnostics (IVD) […]
Molecular point-of-care diagnostic solutions offer improvements in the sensitivity and specificity of existing near-patient and rapid tests while expanding the diagnostic capabilities at points of care, such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world, and are used to assess conditions or admit patients. The concept […]
